Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000912183-14-000006
Filing Date
2014-11-07
Accepted
2014-11-07 09:02:42
Documents
12
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cbst-2014930x10q.htm 10-Q 1229088
2 EXHIBIT 10.1 cbst-ex101_2014930.htm EX-10.1 84883
3 EXHIBIT 31.1 cbst-ex311_2014930.htm EX-31.1 12698
4 EXHIBIT 31.2 cbst-ex312_2014930.htm EX-31.2 12631
5 EXHIBIT 32.1 cbst-ex321_2014930.htm EX-32.1 6722
6 EXHIBIT 32.2 cbst-ex322_2014930.htm EX-32.2 6754
  Complete submission text file 0000912183-14-000006.txt   10462704

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT cbst-20140930.xml EX-101.INS 1876216
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cbst-20140930.xsd EX-101.SCH 51863
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cbst-20140930_cal.xml EX-101.CAL 104866
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cbst-20140930_def.xml EX-101.DEF 242945
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cbst-20140930_lab.xml EX-101.LAB 779577
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cbst-20140930_pre.xml EX-101.PRE 415759
Mailing Address 65 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 65 HAYDEN AVENUE LEXINGTON MA 02421 781-860-8660
CUBIST PHARMACEUTICALS INC (Filer) CIK: 0000912183 (see all company filings)

EIN.: 223192085 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36151 | Film No.: 141202828
SIC: 2834 Pharmaceutical Preparations